These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20502900)

  • 1. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
    Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
    Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
    Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ
    Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
    Choi YW; Lim IK
    Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK; Marrache S; Harn DA; Dhar S
    ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
    Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
    Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.
    Voltan R; Rimondi E; Melloni E; Gilli P; Bertolasi V; Casciano F; Rigolin GM; Zauli G; Secchiero P
    Oncotarget; 2016 Apr; 7(14):18965-77. PubMed ID: 26959881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetate and cancer: new home for an orphan drug?
    Kankotia S; Stacpoole PW
    Biochim Biophys Acta; 2014 Dec; 1846(2):617-29. PubMed ID: 25157892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
    Dhar S; Lippard SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22199-204. PubMed ID: 20007777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.
    Fiebiger W; Olszewski U; Ulsperger E; Geissler K; Hamilton G
    Clin Transl Oncol; 2011 Jan; 13(1):43-9. PubMed ID: 21239354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
    Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
    BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting.
    Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X
    Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichloroacetate induces apoptosis in endometrial cancer cells.
    Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
    Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
    Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
    Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
    Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
    Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of two aspects of metabolism in breast cancer treatment.
    Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
    Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.